Movement Health 2030 brings a wide variety of healthcare stakeholders to the table to identify bottleneck problems in healthcare systems.
Digital health is a broad, multidisciplinary concept that includes concepts from an intersection between technology and healthcare. Digital health applies digital transformation to the healthcare field, incorporating software, hardware and services. Under its umbrella, digital health includes mobile health (mHealth) apps, electronic health records (EHRs), electronic medical records (EMRs), AI, machine learning, robotics, wearable devices, telehealth and telemedicine, as well as personalized medicine.
Patient Centricity is putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family. It means designing a treatment, clinical trial, or other health solution centered around the patient.
By joining Biotech Atelier 2021 on 29th September 2021, you will be able to participate in Big Atelier entitled “The Future of Health – Innovations for Better Healthcare”, the first of our major topics at this-year’s event.
Biotech Atelier always aims to promote the dialogue between companies, start-ups, academia and businesses in the area of biotechnological developments. To achieve this, we unitеd key stakeholders across the field in a Special Edition Atelier focused on “Water and Biotechnologies”.
Are ATMPs the start of a new era in medicine and can we put its beginning for Bulgarian patients? We will look for answers of these and other questions in a seminar on the topic “Scanning the Horizon for Accessibility to Cell and Gene Therapies (ATMPs)”
Do you know what Advanced therapy medicinal products (ATMPs), Digital health and Artificial Intelligence (AI), Real-World Evidence (RWE) and Health Technology Assessment (HTA) and the COVID-19 pandemic have in common? These are the four main topics in the scope of the upcoming Biotech Atelier 2020.
On 25th September 2019 Biotech Atelier 2.0 welcomed 240+ attendees with expertise and interest in biotechnology, IT, healthcare, life science, pharma, regulatory and law. Amongst them were 48 high-profile speakers (scientists, entrepreneurs, futurists, business leaders and investors), who led 10+ hours of engaging panel discussions across 18 topics. They included AI and IT in Medicine, ATMPs, the MEGA project, Biobanking and Biomarkers, Clinical Trials, Genomics, Personalized Medicine, Access to Funding, and much more. One fourth of all guests were high-profile decision makers – board members, c-level executives, heads and directors.